文献速递慢性肾脏病肾小球疾病

肾功能遗传易感性与Malmö饮食与癌症研究中CKD发病率的关系

Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study.
PubMed 文献 · Kidney Int Rep · 2019-05-16

研究纳入Malmö饮食与癌症研究心血管队列中2301例基线eGFR≥60 mL/min/1.73 m²的参与者,构建了53个SNP的加权遗传风险评分(wGRSCKD),随访16.6年后发现wGRSCKD每增加1个标准差,CKD 3A期发病的OR为1.25(95%CI 1.12-1.39),但加入传统风险因素后C统计量未显著改善(P=0.12),而连续净重分类改善指数显著提升(cNRI=21.3%,95%CI 21.2-21.4,P<0.0001)。

要点

  • wGRSCKD与基线及随访时eGFR均强相关(P=6.5×10⁻⁸和P=5.0×10⁻¹⁰)。
  • wGRSCKD每增1个标准差,CKD 3A期发病风险增加25%(OR 1.25,95%CI 1.12-1.39)。
  • wGRSCKD未改善传统风险因素的C统计量,但显著改善风险重分类(cNRI=21.3%)。

核心结论

  • wGRSCKD每增加1个标准差与CKD 3A期发病率增加25%相关。
  • 遗传易感性信息可能有助于将个体重分类至正确风险方向,但未改善模型预测能力。

研究设计与样本

  • 基于Malmö饮食与癌症研究心血管队列,纳入2301例基线eGFR≥60 mL/min/1.73 m²的参与者。
  • 将53个SNP按效应大小加权构建遗传风险评分wGRSCKD,随访平均16.6年,以CKD-EPI 2009肌酐公式评估eGFR。

主要发现

  • 随访结束时453例参与者被定义为CKD 3A期(eGFR≤60 mL/min/1.73 m²)。
  • wGRSCKD与基线eGFR显著相关(P=6.5×10⁻⁸),与随访时eGFR显著相关(P=5.0×10⁻¹⁰)。
  • 调整潜在混杂因素后,wGRSCKD每增1个标准差,CKD 3A期发病的OR为1.25(95%CI 1.12-1.39)。
  • 在传统风险因素基础上加入wGRSCKD未改善C统计量(P=0.12),但cNRI显著改善(21.3%,95%CI 21.2-21.4,P<0.0001)。

关键数值与推荐

  • CKD 3A期定义为eGFR≤60 mL/min/1.73 m²。
  • wGRSCKD由53个SNP按效应大小加权组合而成。

临床怎么用

  • 遗传风险评分可能辅助识别CKD高风险个体并进行风险重分类,但尚不能替代传统临床风险因素。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genome-wide association studies (GWAS) have identified >50 single nucleotide polymorphisms (SNP) in association with estimated glomerular filtration rate (eGFR) and chronic kidney disease (CKD) but little is known about whether the combination of these SNPs may aid in prediction of future incidence of CKD in the population. METHODS: We included 2301 participants with baseline eGFR ≥60 mL/min per 1.73 m2 from the Malmö Diet and Cancer Study-Cardiovascular Cohort. The eGFR was estimated during baseline (1991-1996) and after a mean follow-up of 16.6 years using the CKD-Epidemiology Collaboration 2009 creatinine equation. We combined 53 SNPs into a genetic risk score weighted by the effect size (wGRSCKD), and examined its association with incidence of CKD stage 3A (eGFR ≤60 mL/min per 1.73 m2). RESULTS: At follow-up, 453 study participants were defined as having CKD stage 3A. We observed a strong association between wGRSCKD and eGFR at baseline (P = 6.5 × 10-8) and at the follow-up reexamination (P = 5.0 × 10-10). The odds ratio (OR) for incidence of CKD stage 3A was 1.25 per 1 SD increment in the wGRSCKD (95% confidence interval [CI]: 1.12-1.39) adjusting for potential confounders (sex, age, body mass index [BMI], baseline eGFR, fasting glucose, systolic blood pressure (SBP), antihypertensive treatment, smoking, follow-up time). Adding wGRSCKD on the top of traditional risk factors did not improve the C-statistics (P = 0.12), but the Net Reclassification-Improvement-Index was significantly improved (cNRI = 21.3%; 95% CI: 21.2-21.4; P < 0.0001). CONCLUSION: wGRSCKD was associated with a 25% increased incidence of CKD per 1 SD increment. Although the wGRSCKD did not improve the prediction model beyond clinical risk factors per se, the information of genetic predisposition may aid in reclassification of individuals into correct risk direction.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Schulz CA, Engström G, Christensson A, et al. Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study. Kidney Int Rep. 2019. PMID: 31440704. doi:10.1016/j.ekir.2019.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。